# Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia

> **NCT03852992** · PHASE2 · WITHDRAWN · sponsor: **University of Minnesota**

## Conditions studied

- Male Pattern Hair Loss
- Androgenetic Alopecia
- Male Pattern Baldness

## Interventions

- **DRUG:** Post-Laser Minoxidil 2%
- **DRUG:** At-Home Minoxidil 5%
- **DEVICE:** Laser
- **DRUG:** Post-laser 5mg minoxidil
- **DRUG:** Post-laser 10mg minoxidil
- **DRUG:** Post-laser 20mg minoxidil

## Key facts

- **NCT ID:** NCT03852992
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-09-30
- **Primary completion:** 2023-07-01
- **Final completion:** 2023-07-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was closed with IRB on 10/22/22
- **Last updated:** 2023-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03852992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03852992, "Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03852992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*